Deletion of Tet2 in tumor-infiltrating myeloid cells of melanoma-bearing mice (Mye-Tet2 null mice) led to a significant suppression of in vivo tumor growth, compared to wild-type mice. The gene discussed is TET2; the disease is neoplasm.